Newsfile Corp
28 Jun 2026, 16:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
A class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) and certain officers alleging violations of federal securities laws. — Securities class actions create legal uncertainty, potential financial liabilities, and can damage investor confidence in corporate management.
-0.40The lawsuit targets alleged false or misleading statements made by ADMA between August 9, 2024, and March 25, 2026. — The specific timeframe defines the scope of potential liability and indicates a prolonged period of alleged disclosure failures.
-0.20Which stocks this story touches
The company is facing a class action lawsuit alleging investor harm.
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is the subject of a class action lawsuit alleging federal securities law violations and misleading statements.
The company is facing a class action lawsuit alleging investor harm.
The company is facing a class action lawsuit alleging investor harm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
3h ago
